ANDREW SOLKOVITS: Open Payments
NPI 1487643250 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,716 in 122 payments from 28 companies in 2025. Trend: 2023 $2,545 · 2024 $2,842 · 2025 $2,716
Food & beverage: $2,716
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $818 |
| AstraZeneca Pharmaceuticals LP | 3 | $323 |
| PFIZER INC. | 15 | $268 |
| Novo Nordisk Inc | 12 | $213 |
| Madrigal Pharmaceuticals | 2 | $155 |
| Amgen Inc. | 4 | $120 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $116 |
| Corcept Therapeutics | 4 | $90 |
| Daiichi Sankyo Inc. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
Products named: AIRSUPRA, UBRELVY, VRAYLAR, QULIPTA, REZDIFFRA, NURTEC ODT, EVENITY, Rybelsus.
Industry payments across CA — which companies pay providers there.
